PulseAugur
EN
LIVE 14:05:34
ENTITY Hengrui

Hengrui

PulseAugur coverage of Hengrui — every cluster mentioning Hengrui across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-10-27 funding Hengrui Pharmaceuticals reported an 89% rise in third-quarter net profit, exceeding analyst estimates. source
  2. 2026-05-12 partnership Hengrui and Bristol Myers Squibb entered a global collaboration and licensing agreement. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 2 TOTAL
  1. RESEARCH · CL_325686 ·

    China's Hengrui Pharmaceuticals reports 89% profit surge, exceeding estimates

    Jiangsu Hengrui Pharmaceuticals, a major Chinese drug manufacturer, reported an 89% year-on-year increase in net profit for the third quarter, reaching 2.46 billion yuan. This figure surpassed analyst expectations, driv…
  2. RESEARCH · CL_28170 ·

    Hengrui inks $15.2B global drug development deal with BMS

    Chinese pharmaceutical company Hengrui has entered into a global collaboration and licensing agreement with US giant Bristol Myers Squibb (BMS). The deal, valued at up to US$15.2 billion, involves the development of 13 …